SUMMARY Families in which a single male is affected with a disease which might be either X linked recessive or autosomal recessive present problems in counselling. Before female relatives can be counselled, the probabilities of each mode of inheritance must be assessed, taking into account the prior probabilities, the pedigree structure, any DNA probe data, and any carrier testing data. The widely used linkage analysis package LINKAGE can be used to do the calculation, which is much simpler than the conventional Bayesian method.
When a man has a disease which might be either X linked or autosomal recessive, and there is no family history to indicate the mode of inheritance, counselling his female relatives is difficult. The risks to his sister or daughter differ greatly according to the mode of inheritance. Wolff et all discuss a typical example, two families where an isolated male has a disease which may be either X linked Becker muscular dystrophy (BMD) or autosomal recessive limb girdle muscular dystrophy (LGMD). In each case a sister of the affected man requested counselling about recurrence risks.
In these cases it is necessary to calculate the relative likelihood of X linked or autosomal inheritance in the light of all the available information: the population gene frequencies, the pedigree structure, any DNA probe results, and any carrier tests such as creatine kinase (CK) estimations. TraditionallylA a Bayesian calculation has been used. This approach is indisputably valid in principle. It also fits well with the predilection of geneticists for Bayesian methods. The problem is that the calculation can be very formidable. Few of us could confidently derive an expression such as this': 9/128 s 6 ha hb hc 0 (1_0)2 (03+(1-0)3)+1/64 tL 6 hb hc 0(1-0) 9/128 It 6 ha hb 0(1-0) [hc 03(1-0)+04+hc (1-0)4+0(1-0)31+1/64 L 6 hb 0(1-0) (hc+1)+1/64 R b+3/128 kb 1L (kc+1/2+ka kc+1/2 ka) and even evaluating it arithmetically without making mistakes is tricky. A particular problem with the Bayesian approach is that the form of calculation is different in each family, so that it is not readily computerised.
I wish to suggest an alternative approach, based and that the incidence of the disease in males is 3R 1-f.
For BMD and LGMD suitable values8 are: BMD q=5*0x 10-5 t=5-5x 10-6
LGMD q=6 6x 10-3 [t=0.
RELATIVE PROBABILITIES ON PEDIGREE DATA ALONE
The LINKAGE programs require phenotypes at a second locus in addition to the disease locus. Where there is no relevant marker data, the trick9 is to include a dummy locus with two alleles having gene frequencies 1 and 0, with everybody in the pedigree homozygous for the common allele. The program then calculates the probabilities correctly.
RELATIVE PROBABILITIES INCLUDING DNA MARKER TYPES
If the marker is X linked, the data file for X linked analysis will specify the true recombination frequency, and the data file for the autosomal analysis will have the recombination fraction 0-5. In general, the same pedigree is used for both analyses; how- The log likelihood ratio is 8-822886-8-833303= 0*489856. The odds ratio is the antilog of 0489856= 3-09:1 in favour of LGMD.
For subject 8, the risk that she carries BMD= (chance that the disease is BMD) x (chance that she is a carrier if the disease is BMD)= 1/4-09 x 0-47763 = 0-117. Similarly, the risk that she carries LGMD is 3-09/4-09 x0-66667=0 504.
Discussion
In the particular case of distinguishing BMD and LGMD, molecular genetics may come to the rescue.
Wel0
11 and others'2 have shown that dystrophin cDNA probes detect gene deletions in about 60% of men with BMD, and we have been able to use these probes to make definitive diagnoses of BMD in several men with ill defined neuromuscular disease. Immunological study of the dystrophin in muscle biopsy specimens'3 will probably allow unambiguous diagnosis of all BMD patients. However, the problem of X linked versus autosomal recessive inheritance will remain for many other diseases, and even for BMD where the affected male is dead or unavailable for testing.
The necessity of making two separate runs of the linkage program for the two genetic hypotheses increases the risk of error. A correct result depends on keeping all probabilities strictly comparable between the two runs. This can involve problems of three sorts. First, logical problems: for example, the affected person is bound to be male if he has BMD, but could have been male or female if he has LGMD. Should the resulting factor of 2 difference appear in the quoted likelihoods, given that we would not have asked the question in the first place had it been an affected female? (The answer is yes.) Second, genetic problems: for example, might CK be raised in carriers of LGMD, and what is one to make of the earlier claims that 40% of LGMD is sporadic? Third, computational problems: the need to recode some males as heterozygous and correct the likelihood for the autosomal calculation, as described above. Only the computational problems are specific to the linkage method; the other problems will arise whatever method of calculation is used.
There is little real value in being able to calculate odds to three decimal places, but it is often useful to know what the range of probabilities is in a particular pedigree, and how much it might be changed by, for example, DNA typing some unaffected brothers. For these purposes one needs a computer program which can be set up and then fed with a range of possibilities. Thus I suggest that the advantages of the linkage approach are:
(1) Generality: once the input conditions (the gene frequencies and mutation rates) are set up for a pair of diseases, the program can tackle any pedigree without readjustment. This is particularly useful for exploring the range of possible values in a situation where the true gene frequencies are uncertain. (2) Reliability: there is much less risk of arithmetical slips.
(3) Accessibility: anyone who can use the LINK-AGE package for lod score calculations or risk analysis can follow the methods given here and perform the analysis. Most active genetics departments contain at least one such person, whereas few contain anybody able and willing to undertake the conventional Bayesian calculation.
